GYRE THERAPEUTICS, INC. — Institutional Ownership
Which tracked institutions hold GYRE, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
12
Funds holding
$8821179
Total value held
Buying
10 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $5287650 | 758630 | +38339 | +5.32% |
| 2 | State Street Corp | $1507792 | 216326 | +14101 | +6.97% |
| 3 | Northern Trust Corp | $932872 | 133841 | +4986 | +3.87% |
| 4 | Goldman Sachs Group Inc | $509660 | 73122 | +42014 | +135.06% |
| 5 | Bank Of New York Mellon Corp | $300714 | 43144 | +1941 | +4.71% |
| 6 | Wells Fargo & Company/Mn | $91208 | 12919 | +7361 | +132.44% |
| 7 | Bank Of America Corp /De/ | $73450 | 10538 | +779 | +7.98% |
| 8 | Morgan Stanley | $60227 | 8641 | -45857 | -84.14% |
| 9 | Royal Bank Of Canada | $39000 | 5605 | — | NEW BUY |
| 10 | Barclays Plc | $16031 | 2300 | — | NEW BUY |
| 11 | Citigroup Inc | $1892 | 268 | -116 | -30.21% |
| 12 | Us Bancorp \De\ | $683 | 98 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.